Dr. Margolin specializes in melanoma and other skin cancers with a focus on immunotherapy. She came to St John’s Cancer Institute from the City of Hope, where she worked for a total of 30 years, stopping out for 6 years at University of Washington/Seattle Cancer Care Alliance and 1 year at Stanford’s Department of Medical Oncology.
Dr. Margolin has co-led the Cytokine Working Group and the Cancer Immunotherapy Trials Network, participated in SWOG’s Melanoma Committee, and served ASCO and the Society for Immunotherapy of Cancer in many capacities. She has served on the FDA’s Oncology Drugs Advisory Committee and has been on two advisory committees to the European Organization for the Research and Treatment of Cancer. She has served several melanoma foundations, including Aim at Melanoma, Melanoma Research Alliance and Melanoma Research Foundations in various capacities, including grant review committees, advisory boards and monthly lay-level reviews of timely melanoma topics.
Among Dr. Margolin’s research interests are brain metastasis in melanoma and immunotherapy of skin cancers. She has begun to collaborate with surgeons and laboratory investigators at St John’s and will lead the institute’s efforts in therapeutic trials for advanced melanoma and other cutaneous cancers.